366 related articles for article (PubMed ID: 32304079)
1. Methodology for the Isolation and Analysis of CTCs.
Costa C; Dávila-Ibáñez AB
Adv Exp Med Biol; 2020; 1220():45-59. PubMed ID: 32304079
[TBL] [Abstract][Full Text] [Related]
2. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
3. Relevance of CTC Clusters in Breast Cancer Metastasis.
Piñeiro R; Martínez-Pena I; López-López R
Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
[TBL] [Abstract][Full Text] [Related]
4. Current challenges in metastasis: disseminated and circulating tumor cells detection.
Shahneh FZ
Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
6. Introduction - Biology of Breast Cancer Metastasis and Importance of the Analysis of CTCs.
Piñeiro R
Adv Exp Med Biol; 2020; 1220():1-10. PubMed ID: 32304076
[TBL] [Abstract][Full Text] [Related]
7. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
10. Markers of circulating breast cancer cells.
López-Muñoz E; Méndez-Montes M
Adv Clin Chem; 2013; 61():175-224. PubMed ID: 24015603
[TBL] [Abstract][Full Text] [Related]
11. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
12. Technologies for circulating tumor cell separation from whole blood.
Bankó P; Lee SY; Nagygyörgy V; Zrínyi M; Chae CH; Cho DH; Telekes A
J Hematol Oncol; 2019 May; 12(1):48. PubMed ID: 31088479
[TBL] [Abstract][Full Text] [Related]
13. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.
Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB
Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.
Woo D; Yu M
Transl Res; 2018 Nov; 201():128-135. PubMed ID: 30075099
[TBL] [Abstract][Full Text] [Related]
16. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
Alunni-Fabbroni M; Sandri MT
Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]